News tagged with macular edema
High hsCRP may up risk of macular edema in T1DM
(HealthDay)—For patients with type 1 diabetes mellitus, elevated levels of high-sensitivity C-reactive protein (hsCRP) are associated with an increased risk of clinically significant macular edema (CSME) ...
Ophthalmology
Feb 08, 2013 |
not rated yet |
0
Microaneurysm turnover IDs macular edema development
(HealthDay)—Microaneurysm (MA) turnover independently predicts the development of clinically significant macular edema (CSME) in patients with non-proliferative diabetic retinopathy (NPDR), according to ...
Diabetes
Jan 08, 2013 |
not rated yet |
0
Insulin plus growth factor inhibitor limits vision damage in diabetic mice
A new therapeutic approach to diabetes that combines insulin and an inhibitor of the epidermal growth factor (EGF) betacellulin could limit the progression of diabetic macular edema (DME), Cleveland Clinic researcher Bela ...
Diabetes
Dec 17, 2012 |
5 / 5 (1) |
0
Long-term ranibizumab beneficial for macular edema
(HealthDay)—Long-term aggressive treatment of patients with macular edema with ranibizumab during a third year correlates with reduced mean foveal thickness (FTH) and improved best-corrected visual acuity ...
Ophthalmology
Oct 11, 2012 |
not rated yet |
0
FDA approves drug to treat diabetic macular edema
The U.S. Food and Drug Administration today announced its approval of Lucentis (ranibizumab injection) for the treatment of diabetic macular edema, or DME, an eye condition in people with diabetes that causes blurred vision, ...
Medications
Aug 13, 2012 |
5 / 5 (1) |
0
Thiazolidinedione use in patients with Type 2 diabetes may increase risk for diabetic macular edema
Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year ...
Diabetes
Jun 11, 2012 |
not rated yet |
0
Study reports two-year outcomes of diabetic macular edema treatment
A randomized controlled trial involving patients with persistent clinically significant diabetic macular edema (swelling of the retina) suggests the greater efficacy of bevacizumab compared with macular laser therapy that ...
Ophthalmology
Apr 09, 2012 |
not rated yet |
0
